image
Healthcare - Biotechnology - NASDAQ - US
$ 6.14
-6.4 %
$ 6.77 M
Market Cap
-0.12
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
43.39%
Net Income Estimate
--33.40%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Apollomics, Inc.
image
APLM has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart APLM

image
$14.0m$14.0m$12.0m$12.0m$10.0m$10.0m$8.0m$8.0m$6.0m$6.0m$4.0m$4.0m$2.0m$2.0m$0.0$0.0202320232024202420252025202620262027202720282028
EBIT FORECAST

EBIT Forecast Chart APLM

image
$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)202320232024202420252025202620262027202720282028
NET INCOME FORECAST

Net Income Chart APLM

image
$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)202320232024202420252025202620262027202720282028